Wintrust Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $30K | Sell |
329
-219
| -40% | -$19.7K | 0.03% | 323 |
|
|
2024
Q3 | $46K | Sell |
548
-5,002
| -90% | -$382K | 0.03% | 321 |
|
|
2024
Q2 | $381K | Buy |
5,550
+58
| +1% | +$3.87K | 0.03% | 331 |
|
|
2024
Q1 | $402K | Sell |
5,492
-11,496
| -68% | -$884K | 0.04% | 321 |
|
|
2023
Q4 | $1.38M | Buy |
16,988
+3,621
| +27% | +$282K | 0.13% | 150 |
|
|
2023
Q3 | $1M | Sell |
13,367
-292
| -2% | -$22.5K | 0.1% | 172 |
|
|
2023
Q2 | $1.05M | Sell |
13,659
-2,154
| -14% | -$172K | 0.11% | 163 |
|
|
2023
Q1 | $1.31M | Sell |
15,813
-141
| -0.9% | -$11.7K | 0.17% | 113 |
|
|
2022
Q4 | $1.37M | Buy |
15,954
+73
| +0.5% | +$5.78K | 0.18% | 117 |
|
|
2022
Q3 | $980K | Sell |
15,881
-337
| -2% | -$21.3K | 0.12% | 146 |
|
|
2022
Q2 | $1M | Buy |
16,218
+325
| +2% | +$20.1K | 0.12% | 151 |
|
|
2022
Q1 | $945K | Sell |
15,893
-72,977
| -82% | -$4.66M | 0.09% | 172 |
|
|
2021
Q4 | $6.45M | Buy |
+88,870
| New | +$6.12M | 0.61% | 30 |
|
|
2021
Q3 | – | Sell |
-148,145
| Closed | -$10.2M | – | 329 |
|
|
2021
Q2 | $10.2M | Sell |
148,145
-347
| -0.2% | -$23.2K | 1.05% | 13 |
|
|
2021
Q1 | $9.58M | Buy |
148,492
+32,590
| +28% | +$2.1M | 0.99% | 17 |
|
|
2020
Q4 | $6.75M | Sell |
115,902
-8,149
| -7% | -$492K | 1.92% | 14 |
|
|
2020
Q3 | $7.84M | Buy |
124,051
+17,943
| +17% | +$1.24M | 1.08% | 19 |
|
|
2020
Q2 | $8.16M | Buy |
106,108
+18,228
| +21% | +$1.4M | 1.14% | 18 |
|
|
2020
Q1 | $6.57M | Buy |
87,880
+31,735
| +57% | +$2.19M | 1.08% | 19 |
|
|
2019
Q4 | $3.65M | Sell |
56,145
-8,903
| -14% | -$580K | 0.51% | 38 |
|
|
2019
Q3 | $4.12M | Buy |
65,048
+4,065
| +7% | +$266K | 0.62% | 31 |
|
|
2019
Q2 | $4.12M | Sell |
60,983
-6,647
| -10% | -$437K | 0.62% | 31 |
|
|
2019
Q1 | $4.4M | Sell |
67,630
-4,600
| -6% | -$306K | 0.71% | 30 |
|
|
2018
Q4 | $4.52M | Sell |
72,230
-15,268
| -17% | -$1.07M | 0.84% | 20 |
|
|
2018
Q3 | $6.76M | Buy |
87,498
+11,685
| +15% | +$882K | 1.1% | 16 |
|
|
2018
Q2 | $5.37M | Buy |
75,813
+66,255
| +693% | +$4.68M | 0.93% | 16 |
|
|
2018
Q1 | $721K | Buy |
9,558
+27
| +0.3% | +$2.15K | 0.18% | 107 |
|
|
2017
Q4 | $683K | Sell |
9,531
-391
| -4% | -$29.7K | 0.16% | 134 |
|
|
2017
Q3 | $804K | Sell |
9,922
-10,364
| -51% | -$793K | 0.2% | 109 |
|
|
2017
Q2 | $1.44M | Buy |
20,286
+2,450
| +14% | +$163K | 0.38% | 61 |
|
|
2017
Q1 | $1.21M | Buy |
17,836
+10,680
| +149% | +$751K | 0.34% | 68 |
|
|
2016
Q4 | $512K | Sell |
7,156
-2,520
| -26% | -$187K | 0.21% | 99 |
|
|
2016
Q3 | $766K | Sell |
9,676
-4,805
| -33% | -$390K | 0.35% | 50 |
|
|
2016
Q2 | $47K | Buy |
+14,481
| New | +$1.29M | 0.09% | 99 |
|
Other funds holding GILD
Wintrust Investments's GILD Position: Q4 2024 in Review
Wintrust Investments reduced its Gilead Sciences (GILD) stake by 40% in Q4 2024, selling an estimated $19.7K and leaving 329 shares worth $30K. The position accounts for 0.03% of the portfolio, ranked #323.
Wintrust Investments first reported a position in GILD in Q2 2016 and has held it in 34 quarters since. The position peaked at $10.2M in Q2 2021. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.
- Wintrust Investments held 329 shares of Gilead Sciences worth $30K as of Q4 2024.
- Wintrust Investments sold 219 Gilead Sciences shares in Q4 2024, an estimated $19.7K.
- Gilead Sciences made up 0.03% of Wintrust Investments's portfolio in Q4 2024, its #323 holding.
- Wintrust Investments first reported a position in Gilead Sciences in Q2 2016 and has held it in 34 quarters since.
- Wintrust Investments's Gilead Sciences position peaked at $10.2M in Q2 2021.
- 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.
Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.